organometallic glycogen synthase kinase-3 inhibitors (University of Pennsylvania)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameorganometallic glycogen synthase kinase-3 inhibitors (University of Pennsylvania)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitors
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsDiabetes MellitusNervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A